Solving the riddle of glioblastoma: The hope for immunotherapy

被引：1

作者：

Bashir, Rifaat ^{[1
]}

Mohile, Nimish A. ^{[1
]}

机构：

[1] URMC, Dept Neurol, Rochester, NY USA

来源：

NEUROLOGY | 2016年 / 86卷 / 24期

关键词：

D O I：

10.1212/WNL.0000000000002779

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：2220 / 2221

页数：2

共 10 条

[1] Bioinformatic profiling identifies an immune-related risk signature for glioblastoma [J].

Cheng, Wen ;

Ren, Xiufang ;

Zhang, Chuanbao ;

Cai, Jinquan ;

Liu, Yang ;

Han, Sheng ;

Wu, Anhua .

NEUROLOGY, 2016, 86 (24) :2226-2234

[2] Immunomodulation: checkpoint blockade etc. [J].

Curry, William T. ;

Lim, Michael .

NEURO-ONCOLOGY, 2015, 17 :26-31

[3] The 2007 WHO classification of tumours of the central nervous system (vol 114, pg 97, 2007) [J].

Louis, David N. ;

Ohgaki, Hiroko ;

Wiestler, Otmar D. ;

Cavenee, Webster K. ;

Burger, Peter C. ;

Jouvet, Anne ;

Scheithauer, Bernd W. ;

Kleihues, Paul .

ACTA NEUROPATHOLOGICA, 2007, 114 (05) :547-547

[4] Immunosuppressive mechanisms in glioblastoma [J].

Nduom, Edjah K. ;

Weller, Michael ;

Heimberger, Amy B. .

NEURO-ONCOLOGY, 2015, 17 :9-14

[5] The blockade of immune checkpoints in cancer immunotherapy [J].

Pardoll, Drew M. .

NATURE REVIEWS CANCER, 2012, 12 (04) :252-264

[6] Immune Checkpoint Blockade in Cancer Therapy [J].

Postow, Michael A. ;

Callahan, Margaret K. ;

Wolchok, Jedd D. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) :1974-U161

[7] Therapeutic advances in the treatment of glioblastoma: Rationale and potential role of targeted agents [J].

Reardon, David A. ;

Wen, Patrick Y. .

ONCOLOGIST, 2006, 11 (02) :152-164

[8] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [J].

Stupp, R ;

Mason, WP ;

van den Bent, MJ ;

Weller, M ;

Fisher, B ;

Taphoorn, MJB ;

Belanger, K ;

Brandes, AA ;

Marosi, C ;

Bogdahn, U ;

Curschmann, J ;

Janzer, RC ;

Ludwin, SK ;

Gorlia, T ;

Allgeier, A ;

Lacombe, D ;

Cairncross, JG ;

Eisenhauer, E ;

Mirimanoff, RO ;

Van Den Weyngaert, D ;

Kaendler, S ;

Krauseneck, P ;

Vinolas, N ;

Villa, S ;

Wurm, RE ;

Maillot, MHB ;

Spagnolli, F ;

Kantor, G ;

Malhaire, JP ;

Renard, L ;

De Witte, O ;

Scandolaro, L ;

Vecht, CJ ;

Maingon, P ;

Lutterbach, J ;

Kobierska, A ;

Bolla, M ;

Souchon, R ;

Mitine, C ;

Tzuk-Shina, T ;

Kuten, A ;

Haferkamp, G ;

de Greve, J ;

Priou, F ;

Menten, J ;

Rutten, I ;

Clavere, P ;

Malmstrom, A ;

Jancar, B ;

Newlands, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :987-996

[9] Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial [J].

Stupp, Roger ;

Taillibert, Sophie ;

Kanner, Andrew A. ;

Kesari, Santosh ;

Steinberg, David M. ;

Toms, Steven A. ;

Taylor, Lynne P. ;

Lieberman, Frank ;

Silvani, Antonio ;

Fink, Karen L. ;

Barnett, Gene H. ;

Zhu, Jay-Jiguang ;

Henson, John W. ;

Engelhard, Herbert H. ;

Chen, Thomas C. ;

Tran, David D. ;

Sroubek, Jan ;

Iran, Nam D. ;

Hottinger, Andreas F. ;

Landolfi, Joseph ;

Desai, Rajiv ;

Caroli, Manuela ;

Kew, Yvonne ;

Honnorat, Jerome ;

Idbaih, Ahmed ;

Kirson, Eilon D. ;

Weinberg, Uri ;

Palti, Yoram ;

Hegi, Monika E. ;

Ram, Zvi .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (23) :2535-2543

[10] Malignant gliomas in adults [J].

Wen, Patrick Y. ;

Kesari, Santosh .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (05) :492-507

← 1 →